CivatlasThe Civilization Atlas

Company

Vor Biopharma

Headquarters:
Boston, MA

Description

Develops telitacicept, a BAFF/APRIL inhibitor for autoimmune diseases, aiming to rebalance immunity by blocking survival signals for harmful immune cells.